Navigation Links
Major Illnesses in U.S. Seniors Cost $196 Billion Annually
Date:10/30/2008

These include lung diseases, heart disease, pneumonia and gastrointestinal woes

THURSDAY, Oct. 30 (HealthDay News) -- In 2007, six major illnesses among Americans age 65 and older resulted in medical and lost productivity costs of more than $196 billion, according to researchers who analyzed Medicare and National Health Interview Survey data.

The six major illnesses examined in the study were: chronic lung disease, ischemic heart disease, stroke, lung cancer, pneumonia and gastrointestinal illness. The total cost of the six conditions in 2000 was almost $135 billion. The researchers factored in population growth and increases in medical care costs since then to arrive at the 2007 figure.

In 2000, ischemic heart disease was the most expensive of the six diseases, costing $60 billion. The least expensive was gastrointestinal illness at $500 million.

"As our population continues to age, we expect that the total cost burden of these illnesses will also continue to increase," study lead author George Van Houtven, senior economist at RTI International, said in a news release from the research institute. "To reduce these costs, we need to give priority to prevention strategies including environmental quality improvements."

The study was published in RTI Press.

More information

The National Institute on Aging offers advice for healthy aging.



-- Robert Preidt



SOURCE: RTI International, news release, Oct. 22, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Laboratory at UI plays major role in diagnosing cancer
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. Major grant advances UWs clinical and translational research enterprise
7. Major differences revealed in how local authorities in the UK support disabled people
8. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
11. Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Major Illnesses in U.S. Seniors Cost $196 Billion Annually
(Date:5/4/2016)... Hills, CA (PRWEB) , ... May 04, 2016 , ... ... care that ex-supermodel Janice Dickinson needed following breast cancer surgery. In March 2016, the ... situ, a type of breast cancer that occurs in the milk ducts, according to ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... medical coding, billing and compliance. In upcoming months, AudioEducator has lined up some ... Every conference is designed to give complete compliance know-how and practical, easy-to-apply advice. ...
(Date:5/4/2016)... ... May 03, 2016 – (PRWEB) May ... and child products, today revealed the non-toxic benefits of its Tutti ... deal with teething pain is just part of the story. These ... are BPA-, PVC-, and phthalate-free. , “Many baby toys contain ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... they acquired Pocono Sterilizer, an equipment sterilization service and sales company located in ... provides medical and research-related equipment and asset management services to the medical and ...
(Date:5/4/2016)... Clara, California (PRWEB) , ... May 04, 2016 ... ... organized by United Scientific Group is scheduled on July 25-27, 2016 at Las ... and other health care professionals from educational institutes and research organizations across the ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Actinic Keratosis Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Actinic Keratosis market valuations and forecast, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: